Paired with Roche's HPV testing offerings, the deal will expand its cervical cancer testing capabilities.
The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.
The funds will be used to support clinical trials and commercialization efforts, as well as US regulatory clinical trials for a PMA submission for its CINtec Plus Cytology platform.
The CTAF recommendation is "an important decision-making resource for clinicians and patients," the firm's CEO said.
Patents awarded to GeneNews, US Army, Aisin Seiki, MTM Laboratories, and USC.
Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.
Bill Gates tells the Telegraph that bioterrorism is a serious risk.
The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.
CBS News reports that the White House Science Fair is to continue under President Donald Trump.